Miller Howard Investments’s Novartis NVS Stock Holding History

Miller Howard Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-714,011	Closed	-$46.6M	–	192
2016 Q4	$46.6M	Sell	714,011 -115,676	-14%	-$7.5M	0.89%	47
2016 Q3	$58.7M	Sell	829,687 -80,533	-9%	-$5.87M	1.08%	39
2016 Q2	$67.3M	Sell	910,220 -37,767	-4%	-$2.61M	1.21%	30
2016 Q1	$61.5M	Sell	947,987 -42,367	-4%	-$2.88M	1.14%	34
2015 Q4	$76.4M	Sell	990,354 -84,348	-8%	-$6.7M	1.37%	25
2015 Q3	$88.5M	Sell	1,074,702 -32,294	-3%	-$2.87M	1.47%	22
2015 Q2	$97.5M	Buy	1,106,996 +179,049	+19%	+$16.4M	1.31%	25
2015 Q1	$82M	Buy	927,947 +19,716	+2%	+$1.75M	1.24%	26
2014 Q4	$75.4M	Buy	908,231 +104,295	+13%	+$8.65M	1.16%	30
2014 Q3	$67.8M	Buy	803,936 +10,940	+1%	+$885K	1.05%	30
2014 Q2	$64.3M	Buy	792,996 +14,125	+2%	+$1.11M	1.02%	33
2014 Q1	$59.3M	Buy	+778,871	New	+$56.8M	1.09%	32

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Miller Howard Investments's NVS Position: Q1 2017 in Review

Miller Howard Investments sold out of Novartis (NVS) in Q1 2017, closing a stake of 714,011 shares — an estimated $46.6M sold.

Miller Howard Investments first reported a position in NVS in Q1 2014 and held it in 12 quarters. The position peaked at $97.5M in Q2 2015. 909 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

Miller Howard Investments reported no remaining Novartis position as of Q1 2017 after selling out during the quarter.
Miller Howard Investments sold 714,011 Novartis shares in Q1 2017, an estimated $46.6M.
Miller Howard Investments first reported a position in Novartis in Q1 2014 and held it in 12 quarters.
Miller Howard Investments's Novartis position peaked at $97.5M in Q2 2015.
909 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Miller Howard Investments's 13F filing for Q1 2017, filed 26 Apr 2017.